Nutritionally Complete Oral Nutritional Supplement

Effect of developed ONS on postprandial glycemic response in healthy subjects

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

TCTR

Registry ID

TCTR20210330005

Enrollment

Registered

2021-03-30

Start date

2021-01-15

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

blood glucose, subjective appetite, gastrointestinal tolerability blood glucose

Interventions

100 percent maltodextrin as a carbohydrate source,85 percent maltodextrin and 15 percent resistant maltodextrin as a carbohydrate source,ONS 70 percent maltodextrin and 30 percent resistant maltodextr

Placebo Comparator Dietary Supplement,Experimental Dietary Supplement,Experimental Dietary Supplement

ons,rmd15,rmd30

Eligibility

Sex/Gender

All

Age

18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Healthy subjects, aged 18-55 years old Fasting plasma glucose <100 mg/dl BMI <23 kg/m2

Exclusion criteria

Exclusion criteria: Taking any medication/ herbal supplement/ insulin injection to lower plasma glucose Having any allergies to study product

Design outcomes

Primary

Measure	Time frame
blood glucose 0, 30, 60, 120, 180 min fasting blood glucose	—

Secondary

Measure	Time frame
subjective appetite 0, 30,60, 120, 180 mins VAS questionnairre	—

Countries

Thailand

Contacts

Public Contactsuwimol sapwarobol

Chulalongkorn university

suwimol.sa@chula.ac.th022181524

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026